KP Tissue Releases Second Quarter 2021 Financial Results
KPLP Q2 2021 Business and Financial Highlights • Revenue decreased by $47.5 million or 12.3% to $339.3 million in Q2 2021 compared to $386.8 million in Q2 2020. • Adjusted EBITDA was $37.3 million in Q2 2021 compared to $64.4 million in Q2 2020, a decrease of 42.1%, and similar sequentially to the $37.5 million in Q1 2021. • TAD Sherbrooke continues to run above the expected start-up curve. • Completed financing for the Sherbrooke Expansion Project. • Declared a quarterly dividend of $0.18 per share to be paid on October 15, 2021.